Aging and comorbidities influence the risk of hospitalization and mortality in diabetic patients experiencing severe hypoglycemia.


Journal

Nutrition, metabolism, and cardiovascular diseases : NMCD
ISSN: 1590-3729
Titre abrégé: Nutr Metab Cardiovasc Dis
Pays: Netherlands
ID NLM: 9111474

Informations de publication

Date de publication:
01 2022
Historique:
received: 19 04 2021
revised: 29 08 2021
accepted: 12 09 2021
pubmed: 23 11 2021
medline: 11 3 2022
entrez: 22 11 2021
Statut: ppublish

Résumé

To assess the risk of hospitalization and mortality within 1 year of severe hypoglycaemia and theirs clinical predictors. We retrospectively examined 399 admissions for severe hypoglycemia in adults with DM at the Emergency Department (ED) of the University Hospital of Novara (Italy) between 2012-2017, and we compared the clinical differences between older (aged ≥65 years) and younger individuals (aged 18-64 years). A logistic regression model was used to explore predictors of hospitalization following ED access and 1-year later, according to cardiovascular (CV) or not (no-CV) reasons; 1-year all-cause mortality was also detected. The study cohort comprised 302 patients (median [IQR] age 75 [17] years, 50.3% females, 93.4% white, HbA

Sections du résumé

BACKGROUND AND AIMS
To assess the risk of hospitalization and mortality within 1 year of severe hypoglycaemia and theirs clinical predictors.
METHODS AND RESULTS
We retrospectively examined 399 admissions for severe hypoglycemia in adults with DM at the Emergency Department (ED) of the University Hospital of Novara (Italy) between 2012-2017, and we compared the clinical differences between older (aged ≥65 years) and younger individuals (aged 18-64 years). A logistic regression model was used to explore predictors of hospitalization following ED access and 1-year later, according to cardiovascular (CV) or not (no-CV) reasons; 1-year all-cause mortality was also detected. The study cohort comprised 302 patients (median [IQR] age 75 [17] years, 50.3% females, 93.4% white, HbA

Identifiants

pubmed: 34802847
pii: S0939-4753(21)00456-7
doi: 10.1016/j.numecd.2021.09.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

160-166

Informations de copyright

Copyright © 2021 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No potential conflicts of interest relevant to this article were reported.

Auteurs

Alessandro Nuzzo (A)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy. Electronic address: alessandronuzzo.med@gmail.com.

Andrea Brignoli (A)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Maria C Ponziani (M)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Marco Zavattaro (M)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Flavia Prodam (F)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Luigi M Castello (LM)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy; Emergency Medicine Department, AOU Maggiore della Carità, Novara, Italy.

Gian C Avanzi (GC)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy; Emergency Medicine Department, AOU Maggiore della Carità, Novara, Italy.

Paolo Marzullo (P)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy; Division of General Medicine, Ospedale S. Giuseppe, I.R.C.C.S. Istituto Auxologico Italiano, Verbania, Italy.

Gianluca Aimaretti (G)

Endocrinology, Department of Translational Medicine, Università del Piemonte Orientale, Novara, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH